E-LENS

Lung cancer is the leading cause of cancer-related deaths, often due to late diagnosis and inconsistent follow-up. But what if we could change that?  At Nodule Science, we take a groundbreaking approach to lung nodule detection, risk assessment, and patient management. Powered by the latest advancements in artificial intelligence and imaging technology, our E-LENS (Early Lung Evaluation and Nodule Screening) program ensures that every lung nodule is evaluated with precision—helping clinicians catch lung cancer earlier and improve patient outcomes.

Smarter Nodule Management with AI

Our approach integrates RevealDX, a leading radiomics platform, to provide AI-driven risk assessments for each lung nodule. We then optimize your existing technologies to build a seamless, data-driven ecosystem for:

• AI-powered nodule detection

• Automated nodule tracking

• Intelligent triage and patient follow-up

A Comprehensive, Multidisciplinary Solution

We go beyond technology—we bring together clinical experts across radiology, pulmonology, thoracic surgery, oncology, emergency medicine, and navigation to develop the most effective and scalable lung cancer screening programs.

E-LENS is looking at lung nodules in a whole new way—are you ready to transform your approach?

​

RevealDX is CE Mark, UKMDR,  Health Canada, TGA medical device license approved. The product is not approved for clinical use in any other jurisdiction and the content herein is for informational purposes only.